Meta-analytical methods for estimating outcomes from overall response rate in patients with relapsed/refractory diffuse large B-cell lymphoma

Relapsed/refractory diffuse large B-cell lymphoma (DLBCL) is highly heterogeneous and current trials are investigating new approaches to improve outcomes. Limited data on response endpoints can confound estimation of a treatment effect when designing studies of novel agents in this setting, which ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ling, Lam, Hung, Shou, Yaping, Galaznik, Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524929/
https://www.ncbi.nlm.nih.gov/pubmed/31143374
http://dx.doi.org/10.18632/oncotarget.26904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524929/
https://www.ncbi.nlm.nih.gov/pubmed/31143374
http://dx.doi.org/10.18632/oncotarget.26904

Ejemplares similares